Physician profile
Christopher C Mason
NPI 1710979554
$2,457.36
in general payments reported to CMS, 2019-2025
30 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $950 · 2020: $462 · 2021: $392 · 2022: $233 · 2023: $158 · 2024: $116 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $607.35 | 2019-2022 | |
| Stryker Corporation | $343.38 | 2019-2021 | |
| Zyla Life Sciences, INC. | $311.01 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $193.58 | 2019-2022 | |
| Smith+Nephew, INC. | $138.77 | 2021-2025 | Collagenase Santyl, Renasys Go V2 Home |
| Sebela Pharmaceuticals INC. | $119.75 | 2019 | |
| Melinta Therapeutics, LLC | $72.91 | 2019 | |
| Bioventus LLC | $58.96 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $51.52 | 2021 | |
| Globus Medical, INC. | $49.23 | 2025 | Senza |
| Embody, INC. | $49.02 | 2021-2022 | |
| Integra Lifesciences Corporation | $44.18 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Boston Scientific Corporation | $38.25 | 2023 | |
| Averitas Pharma INC. | $38.21 | 2024-2025 | Qutenza |
| Amgen INC. | $38.17 | 2024 | Krystexxa |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $34.55 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $29.95 | 2023 | A.L.P.S. |
| Medtronic, INC. | $29.49 | 2023-2024 | Intellis Adaptivestim |
| Kowa Pharmaceuticals America, INC. | $27.86 | 2022-2023 | Seglentis |
| Kerecis Limited | $22.97 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $22.33 | 2019 | |
| Highridge Medical LLC | $18.96 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Ibsa Pharma INC. | $17.76 | 2023 | Tirosint, Licart |
| Daiichi Sankyo INC. | $17.33 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.67 | 2019 | |
| Ermi LLC | $15.83 | 2019 | |
| Depuy Synthes Sales INC. | $13.58 | 2025 | |
| Aroa Biosurgery Incorporated | $13.54 | 2025 | |
| Merck Sharp & Dohme LLC | $11.95 | 2019 | |
| Heron Therapeutics, INC. | $10.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.